Biocon Biologics gets EC approval for YESAFILI, biosimilar Aflibercept
The EC decision follows the European Medicines Agency’s CHMP positive opinion recommending approval of YESAFILI in July
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.